Nephrocare Health Services P/E Ratio
Nephrocare Health Services (NEPHROPLUS) P/E ratio is not applicable — EPS (TTM) ₹8.28, 1 consecutive loss quarter. See Healthcare Services peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Consecutive Loss Quarters: 1
Current EPS: ₹8.28
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | -1.12 | -10 | Loss |
| Mar 2025 | 140.89 | 25 | Profit |
| Jun 2025 | 13.10 | 24 | Profit |
| Dec 2025 | 3.43 | 32 | Profit |
| Dec 2024 | 2.47 | 20 | Profit |
Healthcare Services Peers with Valid P/E Ratios — NEPHROPLUS Comparison
Healthcare Services sector average P/E 60.29, median 40.64 — NEPHROPLUS excluded (negative EPS).
Sector Average PE
60.29
Sector Median PE
40.64
Lowest PE
8.3
Profitable Companies
56
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 8.3 | ₹126 | Low |
| Nidan Labs & Healthcare | NIDAN | 9.89 | ₹20 | Low |
| Shanmuga Hospital | SHANMUGA | 12.12 | ₹52 | Low |
| Deccan Health Care | DECCAN | 13.21 | ₹31 | Low |
| One Global Service Provi… | ONEGLOBAL | 13.34 | ₹872 | Low |
| Abate AS Industries | ABATEAS | 15.33 | ₹164 | Moderate |
| Indraprastha Medical Cor… | INDRAMEDCO | 18.95 | ₹3,371 | Moderate |
| Dr Lalchandani Labs | DLCL | 19.19 | ₹8 | Moderate |
| 3B BlackBio DX | 3BBLACKBIO | 20.21 | ₹1,177 | Moderate |
| Medinova Diagnostic Serv… | MEDINOV | 20.28 | ₹44 | Moderate |
Related Analysis
- For live price, revenue and the complete fundamental profile, see NEPHROPLUS share price.
- Browse NEPHROPLUS balance sheet details for revenue, profit, balance sheet and cash flow data.
- Analyse NEPHROPLUS FII DII holdings to track promoter, FII and institutional holdings.